Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC

NCT: NCT07827885 · COMPLETED

NCT IDNCT07827885
StatusCOMPLETED
Start Date2025-07-24
Completion2026-02-28
SponsorFondazione Policlinico Universitario Campus Bio-Medico (OTHER)
First posted
Last updated

Brief Summary

This randomized clinical trial compared two different chest drain sizes, 20 Fr and 24 Fr, in patients undergoing lung lobectomy for lung cancer. The study aimed to determine whether the size of the chest drain affects postoperative recovery. Outcomes included the presence of pneumothorax and pleural effusion, postoperative pain, subcutaneous emphysema, prolonged air leak, duration of chest drainage, and length of hospital stay. A total of 80 patients were randomly assigned in a 1:1 ratio to receive either a 20-Fr or a 24-Fr chest drain.

Frequently Asked Questions

What is 20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC?

20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC is a clinical trial registered under NCT07827885. Current status: COMPLETED.

What is the status of NCT07827885?

The current status of NCT07827885 (20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC) is: COMPLETED.

When did 20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC start?

20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC started on 2025-07-24.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.